Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| LAVA Therapeutics NV | 532,870 | reported | 18 Sept 2025 | tx 6−1,684,434 |
| Oyster Point Pharma, Inc. | 10,448 | reported | 26 Mar 2021 | tx 4+82,491−404,849 |
| Aprea Therapeutics, Inc. | 0 | reported | 07 Oct 2019 | tx 5+2,839,986−2,506,653 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 17 Sept 2025 | SALE | LAVA Therapeutics NV | 362,806 | 1.49 USD | |
| 18 Sept 2025 | SALE | LAVA Therapeutics NV | 366,111 | 1.44 USD | |
| 16 Sept 2025 | SALE | LAVA Therapeutics NV | 307,707 | 1.53 USD | |
| 16 Sept 2025 | SALE | LAVA Therapeutics NV | 192,293 | 1.53 USD | |
| 18 Sept 2025 | SALE | LAVA Therapeutics NV | 228,791 | 1.44 USD | |
| 17 Sept 2025 | SALE | LAVA Therapeutics NV | 226,726 | 1.49 USD | |
| 26 Mar 2021 | OTHER | Oyster Point Pharma, Inc. | 320,368 | 0.00 USD | |
| 26 Mar 2021 | OTHER | Oyster Point Pharma, Inc. | 82,491 | 0.00 USD | |
| 26 Mar 2021 | OTHER | Oyster Point Pharma, Inc. | 82,491 | 0.00 USD | |
| 26 Mar 2021 | OTHER | Oyster Point Pharma, Inc. | 1,990 | 0.00 USD | |
| 07 Oct 2019 | CONVERSION | Aprea Therapeutics, Inc. | 512,995 | — | |
| 07 Oct 2019 | PURCHASE | Aprea Therapeutics, Inc. | 333,333 | 15.00 USD | |
| 07 Oct 2019 | CONVERSION | Aprea Therapeutics, Inc. | 1,993,658 | — | |
| 07 Oct 2019 | CONVERSION | Aprea Therapeutics, Inc. | 512,995 | — | deriv |
| 07 Oct 2019 | CONVERSION | Aprea Therapeutics, Inc. | 1,993,658 | — | deriv |